Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia

Phase 2 Unknown 250 enrolled Tianjin Medical University General Hospital

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Efficacy and Safety of Recombinant human thrombopoietin in patients with severe aplastic anemia and very severe aplastic anemia, a randomized, double-blind, placebo-controlled, II phase, multi-center clinical research.

Timeline

Start: 2016-08
Primary completion: 2019-07
Completion: 2020-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	recombinant human thrombopoietin	Protein / enzyme biologic	—	—

Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia

Summary

Timeline

Drugs

Indications